147 related articles for article (PubMed ID: 19815837)
1. Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways.
Segarra M; Lozano E; Corbera-Bellalta M; Vilardell C; Cibeira MT; Esparza J; Izco N; Bladé J; Cid MC
Haematologica; 2010 Mar; 95(3):456-63. PubMed ID: 19815837
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. II. receptor-mediated Akt/PKB and ERK1/2 activation and transcription factors expression profile.
Shlapatska LM; Kovalevska LM; Gordiienko IM; Sidorenko SP
Exp Oncol; 2014 Sep; 36(3):162-9. PubMed ID: 25265348
[TBL] [Abstract][Full Text] [Related]
3. Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cells.
Lei J; Ingbar DH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L765-71. PubMed ID: 21840963
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of liquiritigenin on migration via downregulation proMMP-2 and PI3K/Akt signaling pathway in human lung adenocarcinoma A549 cells.
Wang Y; Xie S; Liu C; Wu Y; Liu Y; Cai Y
Nutr Cancer; 2012; 64(4):627-34. PubMed ID: 22519916
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.
King WG; Mattaliano MD; Chan TO; Tsichlis PN; Brugge JS
Mol Cell Biol; 1997 Aug; 17(8):4406-18. PubMed ID: 9234699
[TBL] [Abstract][Full Text] [Related]
6. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
Kubiatowski T; Jang T; Lachyankar MB; Salmonsen R; Nabi RR; Quesenberry PJ; Litofsky NS; Ross AH; Recht LD
J Neurosurg; 2001 Sep; 95(3):480-8. PubMed ID: 11565871
[TBL] [Abstract][Full Text] [Related]
7. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
8. The lignan (+)-episesamin interferes with TNF-α-induced activation of VSMC via diminished activation of NF-ĸB, ERK1/2 and AKT and decreased activity of gelatinases.
Freise C; Querfeld U
Acta Physiol (Oxf); 2015 Mar; 213(3):642-52. PubMed ID: 25267105
[TBL] [Abstract][Full Text] [Related]
9. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
10. Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways.
Fornaro M; Steger CA; Bennett AM; Wu JJ; Languino LR
Mol Biol Cell; 2000 Jul; 11(7):2235-49. PubMed ID: 10888665
[TBL] [Abstract][Full Text] [Related]
11. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
12. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma.
Kudo C; Yamakoshi H; Sato A; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
Anticancer Res; 2011 Nov; 31(11):3719-26. PubMed ID: 22110192
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells.
Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S
Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084
[TBL] [Abstract][Full Text] [Related]
14. Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells.
Serova M; Ghoul A; Benhadji KA; Faivre S; Le Tourneau C; Cvitkovic E; Lokiec F; Lord J; Ogbourne SM; Calvo F; Raymond E
Mol Cancer Ther; 2008 Apr; 7(4):915-22. PubMed ID: 18413805
[TBL] [Abstract][Full Text] [Related]
15. The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells.
Crean JK; Finlay D; Murphy M; Moss C; Godson C; Martin F; Brady HR
J Biol Chem; 2002 Nov; 277(46):44187-94. PubMed ID: 12218048
[TBL] [Abstract][Full Text] [Related]
16. Pseudolaric acid B inhibits gastric cancer cell metastasis in vitro and in haematogenous dissemination model through PI3K/AKT, ERK1/2 and mitochondria-mediated apoptosis pathways.
Wang D; Xin Y; Tian Y; Li W; Sun D; Yang Y
Exp Cell Res; 2017 Mar; 352(1):34-44. PubMed ID: 28132880
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide induces VCAM-1 expression and neutrophil adhesion to human tracheal smooth muscle cells: involvement of Src/EGFR/PI3-K/Akt pathway.
Lin WN; Luo SF; Wu CB; Lin CC; Yang CM
Toxicol Appl Pharmacol; 2008 Apr; 228(2):256-68. PubMed ID: 18182168
[TBL] [Abstract][Full Text] [Related]
18. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
19. Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib.
Matsuo M; Sakurai H; Ueno Y; Ohtani O; Saiki I
Cancer Sci; 2006 Feb; 97(2):155-62. PubMed ID: 16441427
[TBL] [Abstract][Full Text] [Related]
20. Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells.
Gonzalez E; Kou R; Michel T
J Biol Chem; 2006 Feb; 281(6):3210-6. PubMed ID: 16339142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
